By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, BIO89-100, is a long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.

Contact Information

Website: www.89bio.com
Main Phone: +1 415 500-4614
Address: 142 Sansome Street
Address 2: Second Floor
State: CA
City / Town: San Francisco
Country: US
Postal Code: 94104

Issuer Information

Exchange: NSD
CEO: Rohan Palekar
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A